CIK 0001715768
TGAN Transphorm, Inc.
Insider trading from SEC Form 4. Last filing Jun 20, 2024.
In brief
Transphorm, Inc. (TGAN) has 54 SEC Form 4 filings on file from 9 insiders, the latest filed on Jun 20, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
23 open-market trades have been scored at TGAN. The newest: KKR Phorm Investors L.P. (10% owner) sold $125M of stock on Jun 20, 2024, filed Jun 20, 2024, scored 57 (moderate). 2 insiders sold within 14 days of each other around May 22, 2024.
14 Form 144 notices of planned sales are on file, the latest filed May 22, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Signals
Open-market buys and sells at Transphorm, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | KKR Phorm Investors L.P. owner sell | $125M 24,411,968 shares | -100% | - | |
| 3Weak | Katharina G. McFarland director sell | $20k 3,996 shares | -5% | - | |
| 3Weak | Kelly Smales director sell | $20k 3,996 shares | -5% | - | |
| 3Weak | Katharina G. McFarland director sell | $4,074 840 shares | -1% | - | |
| 3Weak | Kelly Smales director sell | $2,304 475 shares | -1% | - | |
| 0Weak | Kelly Smales director sell | $3,753 766 shares | -1% | - | |
| 45Moderate | Primit Parikh PRESIDENT AND CEO sell | $29k 6,000 shares | -1% | - | |
| 10Weak | Katharina G. McFarland director sell | $19k 3,996 shares | -5% | - | |
| 10Weak | Kelly Smales director sell | $19k 3,996 shares | -5% | - | |
| 3Weak | Katharina G. McFarland director sell | $4,015 833 shares | -1% | - | |
| 3Weak | Kelly Smales director sell | $2,271 471 shares | -1% | - | |
| 0Weak | Kelly Smales director sell | $2,987 766 shares | -1% | - | |
| 0Weak | Kelly Smales director sell | $7,895 2,187 shares | -3% | - | |
| 3Weak | Katharina G. McFarland director sell | $11k 3,995 shares | -4% | - | |
| 3Weak | Kelly Smales director sell | $10k 3,995 shares | -5% | - | |
| 3Weak | Katharina G. McFarland director sell | $11k 3,515 shares | -4% | - | |
| 3Weak | Kelly Smales director sell | $11k 3,883 shares | -4% | - | |
| 35Weak | Primit Parikh President and COO sell | $20k 3,500 shares | -1% | - | |
| 20Weak | Primit Parikh President and COO sell | $13k 2,000 shares | -1% | - | |
| 37Weak | Cameron McAulay Chief Financial Officer sell | $16k 2,806 shares | -3% | - | |
| 30Weak | Umesh Mishra Chief Technology Officer sell | $10k 1,785 shares | -1% | - | |
| 42Moderate | Primit Parikh President and COO sell | $51k 8,927 shares | -4% | - | |
| 40Moderate | Mario Rivas Chief Executive Officer sell | $20k 3,571 shares | -3% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 22, 2024 | MCFARLAND KATHARINA G. BOD | 3,996 0.01% of outstanding | $20k | May 22, 2024 | $23k |
| May 22, 2024 | Smales Kelly BOD | 3,996 0.01% of outstanding | $20k | May 22, 2024 | $25k |
| Apr 25, 2024 | Smales Kelly BOD | 475 0.00% of outstanding | $2,279 | Apr 24, 2024 | $23k |
| Apr 24, 2024 | MCFARLAND KATHARINA G. BOD | 840 0.00% of outstanding | $4,074 | Apr 24, 2024 | $19k |
| Apr 5, 2024 | Smales Kelly BOD | 766 0.00% of outstanding | $3,753 | Apr 4, 2024 | $30k |
| Mar 1, 2024 | Parikh Primit Director | 6,000 0.01% of outstanding | $29k | Feb 29, 2024 | none |
| Feb 28, 2024 | MCFARLAND KATHARINA G. Director | 3,996 0.01% of outstanding | $19k | Feb 28, 2024 | $25k |
| Feb 28, 2024 | Smales Kelly Director | 3,996 0.01% of outstanding | $19k | Feb 28, 2024 | $23k |
| Jan 25, 2024 | MCFARLAND KATHARINA G. Director | 833 0.00% of outstanding | $4,015 | Jan 24, 2024 | $21k |
| Jan 25, 2024 | Smales Kelly Director | 471 0.00% of outstanding | $2,270 | Jan 24, 2024 | $21k |
| Jan 4, 2024 | Smales Kelly Director | 766 0.00% of outstanding | $2,987 | Jan 4, 2024 | $29k |
| Jan 3, 2024 | Smales Kelly Director | 2,187 0.00% of outstanding | $7,895 | Jan 2, 2024 | $21k |
| Nov 20, 2023 | Smales Kelly Director | 656 0.00% of outstanding | $1,889 | Nov 20, 2023 | $8,762 |
| Nov 17, 2023 | Smales Kelly Director | 2,188 0.00% of outstanding | $5,842 | Nov 17, 2023 | none |
Transactions
The newest 50 of 84 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Katharina G. McFarland director | DDisposition to issuer Common Stock | -81,323 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cameron McAulay Chief Financial Officer | DDisposition to issuer Common Stock | -182,048 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | KKR Phorm Investors L.P. owner | SOpen-market sale Common Stockindirect: See footnotes | -24,411,968 | $5.10 | $125M | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Michael Julian Humphreys director | DDisposition to issuer Common Stock | -91,037 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Common Stock | -359,720 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cynthia J Moreland director | DDisposition to issuer Common Stock | -82,106 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Common Stock | -489,310 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Kelly Smales director | DDisposition to issuer Common Stock | -69,677 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Kelly Smales director | DDisposition to issuer Stock Option (right to buy)derivative | -55,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cynthia J Moreland director | DDisposition to issuer Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Michael Julian Humphreys director | DDisposition to issuer Stock Option (right to buy)derivative | -55,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Katharina G. McFarland director | DDisposition to issuer Stock Option (right to buy)derivative | -55,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -127,238 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -80,891 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cameron McAulay Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -62,168 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cameron McAulay Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -67,722 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -207,228 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -272,298 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cameron McAulay Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -33,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -6,870 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -6,870 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Cameron McAulay Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -70,400 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -105,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -21,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,563 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -1,563 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -4,655 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -4,655 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Umesh Mishra Chief Technology Officer | DDisposition to issuer Stock Option (right to buy)derivative | -115,200 | $0.00 | $0 | 0 | Jun 20, 2024 |
| Jun 20, 2024 | Primit Parikh PRESIDENT AND CEO | DDisposition to issuer Stock Option (right to buy)derivative | -192,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| May 22, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -3,996 | $4.89 | $20k | 69,677 | May 24, 2024 |
| May 22, 2024 | Katharina G. McFarland director | SOpen-market sale Common Stock10b5-1 | -3,996 | $4.89 | $20k | 81,323 | May 24, 2024 |
| Apr 24, 2024 | Katharina G. McFarland director | SOpen-market sale Common Stock10b5-1 | -840 | $4.85 | $4,074 | 85,319 | Apr 26, 2024 |
| Apr 24, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -475 | $4.85 | $2,304 | 73,673 | Apr 26, 2024 |
| Apr 20, 2024 | Michael Julian Humphreys director | AGrant or award Common Stock | +1,409 | $0.00 | $0 | 91,037 | Apr 23, 2024 |
| Apr 20, 2024 | Katharina G. McFarland director | AGrant or award Common Stock | +2,400 | $0.00 | $0 | 86,159 | Apr 23, 2024 |
| Apr 20, 2024 | Cynthia J Moreland director | AGrant or award Common Stock | +1,043 | $0.00 | $0 | 82,106 | Apr 23, 2024 |
| Apr 20, 2024 | Kelly Smales director | AGrant or award Common Stock | +1,356 | $0.00 | $0 | 74,148 | Apr 23, 2024 |
| Apr 4, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -766 | $4.90 | $3,753 | 72,792 | Apr 5, 2024 |
| Feb 29, 2024 | Primit Parikh PRESIDENT AND CEO | SOpen-market sale Common Stock | -6,000 | $4.80 | $29k | 489,310 | Mar 4, 2024 |
| Feb 28, 2024 | Katharina G. McFarland director | SOpen-market sale Common Stock10b5-1 | -3,996 | $4.81 | $19k | 83,759 | Mar 1, 2024 |
| Feb 28, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -3,996 | $4.81 | $19k | 73,558 | Mar 1, 2024 |
| Jan 24, 2024 | Katharina G. McFarland director | SOpen-market sale Common Stock10b5-1 | -833 | $4.82 | $4,015 | 87,755 | Jan 26, 2024 |
| Jan 24, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -471 | $4.82 | $2,271 | 77,554 | Jan 26, 2024 |
| Jan 20, 2024 | Michael Julian Humphreys director | AGrant or award Common Stock | +1,397 | $0.00 | $0 | 89,628 | Jan 23, 2024 |
| Jan 20, 2024 | Katharina G. McFarland director | AGrant or award Common Stock | +2,380 | $0.00 | $0 | 88,588 | Jan 23, 2024 |
| Jan 20, 2024 | Cynthia J Moreland director | AGrant or award Common Stock | +1,035 | $0.00 | $0 | 81,063 | Jan 23, 2024 |
| Jan 20, 2024 | Kelly Smales director | AGrant or award Common Stock | +1,345 | $0.00 | $0 | 78,025 | Jan 23, 2024 |
| Jan 4, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -766 | $3.90 | $2,987 | 76,680 | Jan 5, 2024 |
| Jan 2, 2024 | Kelly Smales director | SOpen-market sale Common Stock10b5-1 | -2,187 | $3.61 | $7,895 | 77,446 | Jan 3, 2024 |
50 of 84 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Michael Julian Humphreysdirector
- KKR Phorm Investors L.P.owner
- Katharina G. McFarlanddirector
- Cameron McAulayChief Financial Officer
- Umesh MishraChief Technology Officer
- Cynthia J Morelanddirector
- Primit ParikhPresident and COO
- Mario RivasChief Executive Officer
- Kelly Smalesdirector
Questions about TGAN
Answered from the filings on this page, as of the latest one.
Are insiders buying TGAN?
No. In the last 90 days no insider at Transphorm, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade TGAN on the open market?
KKR Phorm Investors L.P. (10% owner) sold $125M of TGAN on Jun 20, 2024 and filed the Form 4 on Jun 20, 2024. InsiderTell scored 57 (moderate).
How many insiders file Form 4 at Transphorm, Inc.?
9 people have filed a Form 4 at Transphorm, Inc., among them Michael Julian Humphreys (director), KKR Phorm Investors L.P. (10% owner), Katharina G. McFarland (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.